Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GJB2 | P29033 | 4/20 | 0.41 |
| ▸ | HPSE | Q9Y251 | 7/20 | 0.39 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.37 |
| ▸ | BDNF | P23560 | 3/20 | 0.37 |
| ▸ | PTN | P21246 | 2/20 | 0.37 |
| ▸ | MDK | P21741 | 2/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.35 |
| ▸ | VEGFA | P15692 | 3/20 | 0.34 |
| ▸ | BMP2 | P12643 | 1/20 | 0.34 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.34 |
| ▸ | SHH | Q15465 | 1/20 | 0.34 |
| ▸ | FGF1 | P05230 | 4/20 | 0.33 |
| ▸ | FGF2 | P09038 | 4/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19453257 | 0.94 | GJB2 (0.40) | GJB2HPSECD209BDNFPTN | |
| SCHEMBL18315051 | 0.85 | GJB2 (0.46) | GJB2HPSEVEGFABMP2CXCL12 | |
| SCHEMBL25964309 | 0.84 | LGALS3 (0.46) | GJB2LGALS3 | |
| SCHEMBL17326150 | 0.81 | GJB2 (0.36) | GJB2HPSEVEGFAFGF1FGF2 | |
| SCHEMBL19682240 | 0.78 | CD209 (0.48) | GJB2HPSECD209BDNFPTN | |
| SCHEMBL19453278 | 0.78 | HPSE (0.35) | GJB2HPSECD209VEGFAFGF1 | |
| SCHEMBL18744562 | 0.78 | GJB2 (0.43) | GJB2HPSEVEGFAFGF1FGF2 | |
| SCHEMBL21750082 | 0.78 | CYP2D6 (0.52) | HPSE | |
| SCHEMBL21750081 | 0.78 | CYP2D6 (0.52) | HPSE | |
| SCHEMBL22842843 | 0.78 | LGALS3 (0.46) | GJB2LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017175082-A1 | IMMUNOGENIC COMPOSITIONS | GSK VACCINES S.R.L. (IT) | 2017-10-12 | — | — | WO | disclosed |